465 related articles for article (PubMed ID: 11404392)
1. Different Toll-like receptor agonists induce distinct macrophage responses.
Jones BW; Means TK; Heldwein KA; Keen MA; Hill PJ; Belisle JT; Fenton MJ
J Leukoc Biol; 2001 Jun; 69(6):1036-44. PubMed ID: 11404392
[TBL] [Abstract][Full Text] [Related]
2. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
Means TK; Wang S; Lien E; Yoshimura A; Golenbock DT; Fenton MJ
J Immunol; 1999 Oct; 163(7):3920-7. PubMed ID: 10490993
[TBL] [Abstract][Full Text] [Related]
3. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages.
Jones BW; Heldwein KA; Means TK; Saukkonen JJ; Fenton MJ
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii6-12. PubMed ID: 11890657
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus.
Han SB; Yoon YD; Ahn HJ; Lee HS; Lee CW; Yoon WK; Park SK; Kim HM
Int Immunopharmacol; 2003 Sep; 3(9):1301-12. PubMed ID: 12890428
[TBL] [Abstract][Full Text] [Related]
6. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
Means TK; Lien E; Yoshimura A; Wang S; Golenbock DT; Fenton MJ
J Immunol; 1999 Dec; 163(12):6748-55. PubMed ID: 10586073
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
8. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways.
Bachar O; Adner M; Uddman R; Cardell LO
Eur J Immunol; 2004 Apr; 34(4):1196-207. PubMed ID: 15048731
[TBL] [Abstract][Full Text] [Related]
12. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.
Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V
J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinases and AP-1 by polysaccharide isolated from the radix of Platycodon grandiflorum in RAW 264.7 cells.
Yoon YD; Kang JS; Han SB; Park SK; Lee HS; Kang JS; Kim HM
Int Immunopharmacol; 2004 Nov; 4(12):1477-87. PubMed ID: 15351317
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.
Lin MW; Tsao LT; Chang LC; Chen YL; Huang LJ; Kuo SC; Tzeng CC; Lee MR; Wang JP
Biochem Pharmacol; 2007 Jun; 73(11):1796-806. PubMed ID: 17379190
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum.
Yoon YD; Han SB; Kang JS; Lee CW; Park SK; Lee HS; Kang JS; Kim HM
Int Immunopharmacol; 2003 Dec; 3(13-14):1873-82. PubMed ID: 14636836
[TBL] [Abstract][Full Text] [Related]
16. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
18. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4.
Baumgarten G; Knuefermann P; Nozaki N; Sivasubramanian N; Mann DL; Vallejo JG
J Infect Dis; 2001 Jun; 183(11):1617-24. PubMed ID: 11343210
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
Böcker U; Yezerskyy O; Feick P; Manigold T; Panja A; Kalina U; Herweck F; Rossol S; Singer MV
Int J Colorectal Dis; 2003 Jan; 18(1):25-32. PubMed ID: 12458377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
